T2	Entity 0 18	Vitamin D receptor
T3	SNP 34 38	FokI
T4	SNP 40 44	BsmI
R1	SNP_coupled_gene Arg1:T3 Arg2:T2	
R2	SNP_coupled_gene Arg1:T4 Arg2:T2	
T1	Cancer 50 63	breast cancer
T5	Association 64 68	risk
E1	Association:T5 bc:T1 snp_int:T4 snp_int2:T3
T6	Entity 129 144	French Canadian
R3	Population_assignment Arg1:T3 Arg2:T6	
R4	Population_assignment Arg1:T4 Arg2:T6	
T7	Spec 224 231	studied
T8	Association 236 247	association
E2	Association:T8 snp_int:T10 snp_int2:T11 bc:T12
R5	Speculation_marker Arg1:E2 Arg2:T7	
T9	Entity 275 278	VDR
R6	Equiv Arg1:T9 Arg2:T2	
T10	SNP 358 362	FokI
T11	SNP 367 371	BsmI
R7	SNP_coupled_gene Arg1:T10 Arg2:T9	
R8	SNP_coupled_gene Arg1:T11 Arg2:T9	
T12	Cancer 378 391	breast cancer
T13	Entity 456 471	same population
R9	Equiv Arg1:T13 Arg2:T6	
R10	Population_assignment Arg1:T10 Arg2:T13	
R11	Population_assignment Arg1:T11 Arg2:T13	
T14	Entity 497 528	family history of breast cancer
R12	Risk_Factor Arg1:T10 Arg2:T14	
R13	Risk_Factor Arg1:T11 Arg2:T14	
T15	Entity 684 689;703 722	women Quebec City, Canada
R14	Equiv Arg1:T6 Arg2:T15	
T16	SNP 912 916	FokI
T17	Entity 898 909	FF genotype
R15	Genotype Arg1:T16 Arg2:T17	
T18	SNP 912 916	FokI
T19	Entity 917 919	ff
R16	Genotype Arg1:T18 Arg2:T19	
T20	Cancer 945 958	breast cancer
T21	Level 938 944	higher
T22	Association 959 963	risk
E3	Association:T22 bc:T20 snp_int:T18
R17	Level_marker Arg1:E3 Arg2:T21	
E4	Association:T22 snp_int:T16 bc:T20
T23	Entity 888 896	F allele
R18	SNP_coupled_gene Arg1:T16 Arg2:T23	
T24	Entity 1179 1209	amily history of breast cancer
R19	Population_assignment Arg1:T16 Arg2:T15	
R20	Population_assignment Arg1:T18 Arg2:T15	
R21	SNP_coupled_gene Arg1:T18 Arg2:T9	
R22	SNP_coupled_gene Arg1:T16 Arg2:T9	
T25	Neg 1331 1338	without
R23	Risk_Factor Arg1:T18 Arg2:T24	
R24	Risk_Factor Arg1:T16 Arg2:T24	
T26	Entity 1339 1353	family history
T27	Association 1355 1366	odds ratios
E5	Association:T27 snp_int:T33 bc:T20
T28	Entity 1447 1449	FF
T29	Entity 1451 1453	Ff
T30	Entity 1458 1460	ff
R25	Negation_marker Arg1:T26 Arg2:T25	
T31	SNP 912 916	FokI
T32	SNP 912 916	FokI
T33	SNP 912 916	FokI
R26	Genotype Arg1:T33 Arg2:T28	
R27	Risk_Factor Arg1:T33 Arg2:T26	
R28	SNP_coupled_gene Arg1:T33 Arg2:T9	
R29	Population_assignment Arg1:T33 Arg2:T15	
R31	Risk_Factor Arg1:T32 Arg2:T26	
R33	Population_assignment Arg1:T32 Arg2:T15	
R34	Risk_Factor Arg1:T31 Arg2:T26	
R35	Genotype Arg1:T32 Arg2:T30	
R30	Genotype Arg1:T31 Arg2:T29	
R32	Population_assignment Arg1:T31 Arg2:T15	
R36	SNP_coupled_gene Arg1:T31 Arg2:T9	
R37	SNP_coupled_gene Arg1:T32 Arg2:T9	
E6	Association:T27 snp_int:T32 bc:T20
E7	Association:T27 snp_int:T32 bc:T20
T34	Neg 1372 1376	1.00
T35	Effect_Type 1406 1410	1.57
T36	Effect_Type 1378 1382	1.27
R38	Negation_marker Arg1:E5 Arg2:T34	
R39	Effect_type_marker Arg1:E7 Arg2:T36	
R40	Effect_type_marker Arg1:E6 Arg2:T35	
T37	SNP 1489 1493	BsmI
T38	Entity 1494 1496	Bb
T39	Entity 1497 1499	bb
T40	SNP 1489 1493	BsmI
R41	Genotype Arg1:T37 Arg2:T38	
R42	Genotype Arg1:T40 Arg2:T39	
T41	Level 1533 1553	weak non-significant
T42	Effect_Type 1554 1563	increased
T43	Association 1564 1568	risk
E8	Association:T43 snp_int:T40 snp_int2:T37 bc:T20
A1	Effect_Type E8 Increase
A2	Level E8 Low
R43	Effect_type_marker Arg1:E8 Arg2:T42	
R44	Level_marker Arg1:E8 Arg2:T41	
T44	Neg 1625 1632	without
T45	Entity 1650 1664	family history
R45	Negation_marker Arg1:T45 Arg2:T44	
R46	Risk_Factor Arg1:T37 Arg2:T45	
R47	Risk_Factor Arg1:T40 Arg2:T45	
T46	SNP 1842 1846	FokI
T47	Association 1817 1829	associations
E9	Association:T47 snp_int:T46 bc:T50
T48	Entity 1838 1841	VDR
R48	SNP_coupled_gene Arg1:T46 Arg2:T48	
T49	Spec 1780 1787	suggest
R49	Speculation_marker Arg1:E9 Arg2:T49	
T50	Cancer 1851 1864	breast cancer
T51	Entity 1955 1986	family history of breast cancer
R50	Risk_Factor Arg1:T46 Arg2:T51	
R51	Population_assignment Arg1:T46 Arg2:T15	
A3	Effect_Type E6 Increase
